Mercer Global Advisors Inc. ADV Purchases Shares of 5,543 Clorox Co (CLX)

Mercer Global Advisors Inc. ADV purchased a new stake in Clorox Co (NYSE:CLX) during the first quarter, Holdings Channel reports. The firm purchased 5,543 shares of the company’s stock, valued at approximately $854,000.

A number of other large investors have also recently added to or reduced their stakes in CLX. JPMorgan Chase & Co. lifted its position in shares of Clorox by 5.2% during the third quarter. JPMorgan Chase & Co. now owns 1,019,248 shares of the company’s stock worth $153,305,000 after purchasing an additional 50,360 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Clorox by 15.1% during the third quarter. Bank of New York Mellon Corp now owns 1,664,803 shares of the company’s stock worth $250,403,000 after purchasing an additional 218,364 shares in the last quarter. Allianz Asset Management GmbH lifted its position in shares of Clorox by 16.1% during the third quarter. Allianz Asset Management GmbH now owns 23,996 shares of the company’s stock worth $3,609,000 after purchasing an additional 3,319 shares in the last quarter. Pacer Advisors Inc. lifted its position in shares of Clorox by 18.7% during the third quarter. Pacer Advisors Inc. now owns 7,037 shares of the company’s stock worth $1,058,000 after purchasing an additional 1,108 shares in the last quarter. Finally, Man Group plc lifted its position in shares of Clorox by 123.9% during the third quarter. Man Group plc now owns 14,578 shares of the company’s stock worth $2,193,000 after purchasing an additional 8,066 shares in the last quarter. Hedge funds and other institutional investors own 76.90% of the company’s stock.

In other Clorox news, SVP Matthew T. Laszlo sold 10,585 shares of the company’s stock in a transaction that occurred on Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total value of $1,628,925.65. Following the completion of the sale, the senior vice president now owns 17,994 shares of the company’s stock, valued at $2,769,096.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Andrew J. Mowery sold 5,340 shares of the company’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $156.44, for a total transaction of $835,389.60. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by corporate insiders.

CLX opened at $152.34 on Wednesday. The company has a quick ratio of 0.66, a current ratio of 1.15 and a debt-to-equity ratio of 3.08. The company has a market cap of $19.79 billion, a P/E ratio of 25.53, a price-to-earnings-growth ratio of 3.86 and a beta of 0.32. Clorox Co has a fifty-two week low of $113.57 and a fifty-two week high of $167.70.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, February 4th. The company reported $1.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.32 by $0.08. The business had revenue of $1.47 billion during the quarter, compared to the consensus estimate of $1.47 billion. Clorox had a net margin of 12.65% and a return on equity of 105.97%. Clorox’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.77 earnings per share. On average, equities research analysts anticipate that Clorox Co will post 6.31 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a $0.96 dividend. This represents a $3.84 annualized dividend and a yield of 2.52%. The ex-dividend date is Tuesday, April 23rd. Clorox’s payout ratio is presently 61.34%.

CLX has been the topic of a number of research reports. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $177.00 target price on the stock in a research report on Monday, March 11th. BMO Capital Markets set a $175.00 target price on shares of Clorox and gave the stock a “buy” rating in a research report on Tuesday, February 5th. Wells Fargo & Co reiterated a “hold” rating and set a $157.00 target price on shares of Clorox in a research report on Monday, February 4th. Barclays reissued a “hold” rating and set a $142.00 price target on shares of Clorox in a research note on Wednesday, February 6th. Finally, Citigroup set a $171.00 price target on shares of Clorox and gave the stock a “hold” rating in a research note on Tuesday, February 5th. Six analysts have rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company. Clorox presently has a consensus rating of “Hold” and an average target price of $151.21.

TRADEMARK VIOLATION NOTICE: This article was posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thelincolnianonline.com/2019/04/17/mercer-global-advisors-inc-adv-purchases-shares-of-5543-clorox-co-clx.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: How to Invest in the Dividend Aristocrat Index

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.